Medline ® Abstract for Reference 38
of 'Hospice: Philosophy of care and appropriate utilization in the United States'
Length of survival in hospice for cancer patients referred from a comprehensive cancer center.
Younis T, Milch R, Abul-Khoudoud N, Lawrence D, Mirand A, Levine E
Am J Hosp Palliat Care. 2009;26(4):281.
This retrospective study examined 180 hospice patients referred from a comprehensive cancer center over 6 months in 2002 to (1) identify the variables associated with shorter length of survival (LOS) in hospice and (2) examine the LOS in hospice for those who previously participated in clinical trials and/or phase I studies. The median LOS in hospice for this cohort was 35 days. In multivariate analysis, low Palliative Performance Score (PPS) at hospice enrollment and male gender were associated with shorter LOS in hospice: males with low PPS had the shortest LOS while females with high PPS had the longest LOS. No correlation was found between the LOS in hospice and prior participation in clinical trials and/or phase I studies.
Queen Elizabeth II Health Sciences Centre, Nova Scotia, Canada. email@example.com